Part 4 — Side by Side: What the Evidence Actually Supports
- Jesse Christianson
- 2 days ago
- 2 min read
A research-grounded comparison of where THC and CBN stand in the sleep science literature
Sleep Outcome | THC | CBN |
Sleep onset latency (falling asleep faster) | Supported Acute THC consistently associated with faster sleep onset in short-term use across multiple studies | Limited No direct sleep latency data from controlled human trials to date |
Sleep maintenance (staying asleep, nighttime awakenings) | Mixed Acute: modest benefit. Chronic: tolerance develops, WASO increases in long-term users | Emerging Bonn-Miller 2024 RCT shows reduced nighttime awakenings vs. placebo — strongest CBN signal to date |
REM sleep effects | Suppresses Strong, consistent evidence of REM reduction and REM latency extension — beneficial for PTSD nightmares, potentially problematic for others | Unknown No human polysomnography data yet — CUPID trial (Woolcock Institute) will address this |
Slow-wave (deep) sleep | Increases Acute THC associated with greater time in deep NREM sleep — this may partially offset REM suppression concerns | Unknown Awaiting PSG data from active trials |
Psychoactivity | High CB1 agonism produces intoxication at therapeutic doses — barrier for some patients; preference for others | Minimal No reliable psychoactive effect reported in human trials up to 300 mg |
Tolerance development | Well-documented Sleep benefits diminish with regular nightly use; withdrawal causes rebound insomnia | Unknown No long-term tolerance data in humans yet |
Human clinical trial evidence | Moderate Multiple RCTs and PSG studies across insomnia, PTSD, and pain populations | Early Two significant RCTs (subjective measures) + one PSG trial in progress |
Nighttime comfort / wind-down | Supported Consistent self-report and observational data supporting bedtime relaxation | Emerging TruCBN trial showed stress reduction secondary finding at 100 mg |
Patient population fit | PTSD sleep disturbance, nightmare disorder, pain-related insomnia, sleep onset difficulty | Sleep maintenance complaints, patients who want non-psychoactive option, nighttime awakening issues |
Over the next few days, we’ll begin digging deeper into the terpene profiles themselves:🌿 β-myrcene🌿 linalool🌿 β-caryophyllene
…and why they were intentionally selected in our formulations.
Because the real question was never simply:“THC or CBN?”
It was always:“What is the whole formulation doing together?”



Comments